Report ID: PMRREP34568
Number of Pages: 210
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: June-2024
1. Executive Summary
1.1. Global Yersinia Diagnostics Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 – 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Disease Epidemiology
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Supply Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter’s Five Force Analysis
4. Global Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023–2031
4.3. Global Yersinia Diagnostics Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2018 – 2022
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
4.3.3.1. Instruments
4.3.3.2. Kits and Reagents
4.4. Market Attractiveness Analysis: Product
4.5. Global Yersinia Diagnostics Market Outlook: Diagnostic Test
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2018 – 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
4.5.3.1. Stool Culture
4.5.3.2. Imaging Tests
4.5.3.3. Serological Tests
4.5.3.4. Colonoscopy
4.5.3.5. Others
4.6. Market Attractiveness Analysis: Diagnostic Test
4.7. Global Yersinia Diagnostics Market Outlook: Technology
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2018 – 2022
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
4.7.3.1. Immunoassay
4.7.3.2. DNA Probes
4.7.3.3. Polymerase Chain Reaction (PCR)
4.7.3.4. Flow Cytometry
4.7.3.5. Chromatography
4.7.3.6. Others
4.8. Market Attractiveness Analysis: Technology
4.9. Global Yersinia Diagnostics Market Outlook: End User
4.9.1. Introduction / Key Findings
4.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 – 2022
4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
4.9.3.1. Hospitals
4.9.3.2. Public Health Laboratories
4.9.3.3. Commercial Laboratories
4.9.3.4. Others
4.10. Market Attractiveness Analysis: End User
5. Global Yersinia Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 – 2022
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 – 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
6.2.1. By Country
6.2.2. By Product
6.2.3. By Diagnostic Test
6.2.4. By Technology
6.2.5. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
6.4.1. Instruments
6.4.2. Kits and Reagents
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
6.5.1. Stool Culture
6.5.2. Imaging Tests
6.5.3. Serological Tests
6.5.4. Colonoscopy
6.5.5. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
6.6.1. Immunoassay
6.6.2. DNA Probes
6.6.3. Polymerase Chain Reaction (PCR)
6.6.4. Flow Cytometry
6.6.5. Chromatography
6.6.6. Others
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
6.7.1. Hospitals
6.7.2. Public Health Laboratories
6.7.3. Commercial Laboratories
6.7.4. Others
6.8. Market Attractiveness Analysis
7. Europe Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
7.2.1. By Country
7.2.2. By Product
7.2.3. By Diagnostic Test
7.2.4. By Technology
7.2.5. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
7.4.1. Instruments
7.4.2. Kits and Reagents
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
7.5.1. Stool Culture
7.5.2. Imaging Tests
7.5.3. Serological Tests
7.5.4. Colonoscopy
7.5.5. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
7.6.1. Immunoassay
7.6.2. DNA Probes
7.6.3. Polymerase Chain Reaction (PCR)
7.6.4. Flow Cytometry
7.6.5. Chromatography
7.6.6. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
7.7.1. Hospitals
7.7.2. Public Health Laboratories
7.7.3. Commercial Laboratories
7.7.4. Others
7.8. Market Attractiveness Analysis
8. East Asia Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
8.2.1. By Country
8.2.2. By Product
8.2.3. By Diagnostic Test
8.2.4. By Technology
8.2.5. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
8.4.1. Instruments
8.4.2. Kits and Reagents
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
8.5.1. Stool Culture
8.5.2. Imaging Tests
8.5.3. Serological Tests
8.5.4. Colonoscopy
8.5.5. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
8.6.1. Immunoassay
8.6.2. DNA Probes
8.6.3. Polymerase Chain Reaction (PCR)
8.6.4. Flow Cytometry
8.6.5. Chromatography
8.6.6. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
8.7.1. Hospitals
8.7.2. Public Health Laboratories
8.7.3. Commercial Laboratories
8.7.4. Others
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
9.2.1. By Country
9.2.2. By Product
9.2.3. By Diagnostic Test
9.2.4. By Technology
9.2.5. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
9.4.1. Instruments
9.4.2. Kits and Reagents
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
9.5.1. Stool Culture
9.5.2. Imaging Tests
9.5.3. Serological Tests
9.5.4. Colonoscopy
9.5.5. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
9.6.1. Immunoassay
9.6.2. DNA Probes
9.6.3. Polymerase Chain Reaction (PCR)
9.6.4. Flow Cytometry
9.6.5. Chromatography
9.6.6. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
9.7.1. Hospitals
9.7.2. Public Health Laboratories
9.7.3. Commercial Laboratories
9.7.4. Others
9.8. Market Attractiveness Analysis
10. Latin America Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
10.2.1. By Country
10.2.2. By Product
10.2.3. By Diagnostic Test
10.2.4. By Technology
10.2.5. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
10.4.1. Instruments
10.4.2. Kits and Reagents
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
10.5.1. Stool Culture
10.5.2. Imaging Tests
10.5.3. Serological Tests
10.5.4. Colonoscopy
10.5.5. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
10.6.1. Immunoassay
10.6.2. DNA Probes
10.6.3. Polymerase Chain Reaction (PCR)
10.6.4. Flow Cytometry
10.6.5. Chromatography
10.6.6. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
10.7.1. Hospitals
10.7.2. Public Health Laboratories
10.7.3. Commercial Laboratories
10.7.4. Others
10.8. Market Attractiveness Analysis
11. Middle East & Africa Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022
11.2.1. By Country
11.2.2. By Product
11.2.3. By Diagnostic Test
11.2.4. By Technology
11.2.5. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031
11.4.1. Instruments
11.4.2. Kits and Reagents
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031
11.5.1. Stool Culture
11.5.2. Imaging Tests
11.5.3. Serological Tests
11.5.4. Colonoscopy
11.5.5. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031
11.6.1. Immunoassay
11.6.2. DNA Probes
11.6.3. Polymerase Chain Reaction (PCR)
11.6.4. Flow Cytometry
11.6.5. Chromatography
11.6.6. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031
11.7.1. Hospitals
11.7.2. Public Health Laboratories
11.7.3. Commercial Laboratories
11.7.4. Others
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. TestLine Clinical Diagnostics s.r.o
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. CERTEST BIOTEC
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. T2 Biosystems
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Demeditec Diagnostics GmbH
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Launch Diagnostics Limited
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. ELITech Group
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Advanced Molecular Diagnostics
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. SeraCare (LGC Clinical Diagnostics)
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Hygiena LLC
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Diagnostiki Athinon
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. QED Bioscience Inc.
12.3.11.1. Overview
12.3.11.2. Segments and Products
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
12.3.12. BioFire Defense
12.3.12.1. Overview
12.3.12.2. Segments and Products
12.3.12.3. Key Financials
12.3.12.4. Market Developments
12.3.12.5. Market Strategy
12.3.13. VIROTECH Diagnostics GmbH
12.3.13.1. Overview
12.3.13.2. Segments and Products
12.3.13.3. Key Financials
12.3.13.4. Market Developments
12.3.13.5. Market Strategy
12.3.14. Thermo Fisher Scientific Inc.
12.3.14.1. Overview
12.3.14.2. Segments and Products
12.3.14.3. Key Financials
12.3.14.4. Market Developments
12.3.14.5. Market Strategy
12.3.15. Seegene Inc.
12.3.15.1. Overview
12.3.15.2. Segments and Products
12.3.15.3. Key Financials
12.3.15.4. Market Developments
12.3.15.5. Market Strategy
12.3.16. Diasorin S.p.A.
12.3.16.1. Overview
12.3.16.2. Segments and Products
12.3.16.3. Key Financials
12.3.16.4. Market Developments
12.3.16.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
